EIT Pharma
Latest round
- Series A
Last raised
- Aug 2026
Total raised
- $35M
Investors
- 2
About EIT Pharma
Founded in 2026 and based in Washington, US, EIT Pharma, Inc. operates as a pharmaceutical company that develops treatments for hepatitis D and acute respiratory infections.
Who invested in EIT Pharma
2 investors across 1 round
See all investors in EIT Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 31, 2026
Amount
$35M
Investors
Questions about EIT Pharma
Who invested in EIT Pharma?
EIT Pharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EIT Pharma raised?
EIT Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EIT Pharma last raise money?
EIT Pharma's most recent round on record is a Series A, in Aug 2026.
What does EIT Pharma do?
Founded in 2026 and based in Washington, US, EIT Pharma, Inc.
Where is EIT Pharma headquartered?
EIT Pharma is headquartered in Kirkland, US.
Which VCs invest in companies like EIT Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at EIT Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like EIT Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.